Lynch syndrome, a mutation of four genes involved in DNA repair, is associated with increased risk of developing a range of cancers, particularly colorectal cancer (CRC).
Oct 29, 2019
0
2
Spending an hour in talk therapy with a trained counselor costs much more, and takes more time, than swallowing an inexpensive antidepressant pill. But for people with a new diagnosis of major depression, the costs and benefits ...
Oct 28, 2019
1
231
(HealthDay)—International trips for specialty plastic surgeries can be cost-effective or very cost-effective for several conditions, according to a study published in the September issue of Plastic and Reconstructive Surgery.
Oct 15, 2019
0
2
An essential medicines list in Canada should be evidence-based and independent of conflicting interests, found a study of decision-makers and policy-makers that is published in CMAJ (Canadian Medical Association Journal).
Oct 7, 2019
0
1
More than 40 million Americans suffer from varicose veins, which can be both unsightly and painful, but the best way to get rid of them hasn't been clear.
Sep 5, 2019
0
3
Broad distribution of the opioid reversal drug naloxone is highly cost-effective in reducing fatal overdoses, according to a new University of Michigan study.
Aug 21, 2019
0
35
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care ...
May 21, 2019
0
1
(HealthDay)—Legalization of recreational cannabis is not associated with changes in health care utilization, as measured by length of stay or health care costs, according to a study published in the May issue of BMJ Open.
May 16, 2019
0
1
(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk human papillomavirus (hrHPV) ...
May 14, 2019
0
1
Co-led by the London School of Hygiene & Tropical Medicine and the KEMRI-Wellcome Trust Research Programme, the Pneumococcal Conjugate Vaccine Impact Study estimated that continuing the vaccine beyond 2022 would prevent—in ...
Apr 16, 2019
0
1
